--- title: "UK Domestic Plasma Fractionation Service" ocid: "ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a.json" source: "Contracts Finder" current_stage: "Tender" buyer: "NHS ENGLAND" published: "2022-04-11" --- # UK Domestic Plasma Fractionation Service Buyer: NHS ENGLAND Current stage: Tender OCID: ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a.json) ## Summary The procurement process involves NHS England, which is seeking a supplier for the "UK Domestic Plasma Fractionation Service." This project falls under the healthcare industry, specifically involving immunoglobulins, and is located in the United Kingdom. Currently in the Tender stage, this competitive dialogue process aims to select a single organisation to provide a toll fractionation service using UK plasma. Key dates include the deadline for completing the Selection Questionnaire on 12th May 2022, with the contract period set to run from 1st November 2022 until 31st October 2027. This tender presents significant opportunities for businesses that specialise in plasma fractionation and related services, particularly those capable of meeting the specific needs outlined by NHS England. Companies experienced in manufacturing medicinal products from plasma or those with expertise in health service collaborations may find this a suitable opportunity to participate in a strategic initiative aimed at achieving partial self-sufficiency for the NHS. Engaging in this procurement could enhance their visibility and market position within the UK healthcare system while contributing to public health outcomes. ## Notice NHS England and NHS Improvement (NHSE&I) in conjunction with NHS Blood and Transplant (NHSBT) issued Prior Information Notices (PIN) in August 2021 and January 2022, seeking to gather information and feedback from the plasma fractionation market, as recognised experts, to help inform the strategy to contract for fractionation services using UK plasma. Having reflected upon the feedback received, NHSE&I is now commencing a Competitive Dialogue process, to select a single organisation to provide a toll fractionation service using UK plasma. The UK recognises that medicinal products derived from UK plasma have not been manufactured for more than 20 years. As such there is a much to learn and/or relearn. This procurement, and the wider project its supports, are therefore seen as the UK's initial step (or pilot project) to achieve partial self-sufficiency for plasma derived medicinal products for the exclusive use of NHS patients in the UK. As such, this procurement is not expected to be a one off exercise. Rather the learning from this project is expected to inform future procurements and how the UK works with selected fractionators to achieve its long term ambitions for self-sufficiency. As regards Northern Ireland, Scotland and Wales, the respective Blood Services (represented by their hosting bodies where applicable) for each of the regions have expressed interest in this procurement. Therefore the Blood Services for each region (including their hosting bodies where applicable), the Devolved Administration for each region and the NHS providers in each region (as potential buyers of products derived from fractionation) are included by NHSE&I as Participating Authorities ("PAs") within this Contract Notice, as further defined in the tender documents. This provides an option for each of the above bodies to be a party to the contractual arrangements that will result from this procurement (by entering into essentially identical but separate contracts, under the law and jurisdiction of the relevant region in each case), but does not bind them to do so. Further details of the decision and implementation processes for the PAs in Northern Ireland, Scotland and Wales will be provided during the next stage of this procurement (Invitation to Participate in Dialogue The Authority and PA's reserve the right to amend any plasma volumes stated within the procurement documents. Interested organisations can register their interest and access the procurement documents for full details here https://health-family.force.com/s/Welcome Once registered, you will be invited to sign a tripartite non-disclosure agreement (NDA). If you have previously signed an NDA as part of the 2 PIN notices issued for this tender, the NDA continues to apply during the tender period and until a contract has been entered into. The deadline for completion of the Selection Questionnaire within Atamis is 12th May 2022 at 13:00hrs ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/58ec297b-7c1b-433a-b1d0-1dab0fabe8a3 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Goods | | Procurement method | Selective | | Procurement method details | Competitive dialogue (above threshold) | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 11 Apr 2022 | | Submission deadline | 12 May 2022 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | 1 Nov 2022 - 31 Oct 2027 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Not specified | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Locality | LEEDS | | Post town | Leeds | | Postcode | LS2 7UE | | Country | England | | ITL 1 | TLE Yorkshire and The Humber | | ITL 2 | TLE4 West Yorkshire | | ITL 3 | TLE42 Leeds | | Local authority | Leeds | | Electoral ward | Little London & Woodhouse | | Westminster constituency | Leeds Central and Headingley | | Delivery location | Not specified | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33651520 - Immunoglobulins ## Release History - 11 Apr 2022 at 17:41 - Tender - Tender Notice - https://www.contractsfinder.service.gov.uk/Notice/58ec297b-7c1b-433a-b1d0-1dab0fabe8a3 ## Documents - https://www.contractsfinder.service.gov.uk/Notice/58ec297b-7c1b-433a-b1d0-1dab0fabe8a3 11th April 2022 - Opportunity notice on Contracts Finder ## Notice URLs - https://health-family.force.com/s/Welcome ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-b9db849b-a878-4794-9a53-58e7a1c1ed2a.json.